U.S. markets open in 2 hours 32 minutes

Aprea Therapeutics, Inc. (APRE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.5500-0.2700 (-5.60%)
At close: 4:00PM EDT
4.4600 -0.09 (-1.98%)
Pre-Market: 06:30AM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
0
0
0
0
0
Operating Expense
51,128
52,811
29,544
16,489
15,852
Operating Income
-51,128
-52,811
-29,544
-16,489
-15,852
Net Non Operating Interest Income Expense
-2.847
222.652
156.351
-0.182
-0.015
Other Income Expense
-2,616
-890.252
1,328
961.316
662.14
Pretax Income
-53,747
-53,479
-28,060
-15,528
-15,190
Net Income Common Stockholders
-53,747
-53,479
-28,060
-15,528
-15,190
Diluted NI Available to Com Stockholders
-53,747
-53,479
-28,060
-15,528
-15,190
Basic EPS
-
-2.53
-4.67
-1.65
-1.08
Diluted EPS
-
-2.53
-4.67
-1.65
-1.08
Basic Average Shares
-
21,134
6,002
9,429
14,076
Diluted Average Shares
-
21,134
6,002
9,429
14,076
Total Expenses
51,128
52,811
29,544
16,489
15,852
Net Income from Continuing & Discontinued Operation
-53,747
-53,479
-28,060
-15,528
-15,190
Normalized Income
-51,131
-52,589
-29,388
-16,490
-15,852
Interest Expense
-
-
-
0.182
0.015
Net Interest Income
-2.847
222.652
156.351
-0.182
-0.015
EBIT
-51,128
-52,811
-29,544
-15,528
-15,852
EBITDA
-50,890
-
-
-
-
Reconciled Depreciation
237.84
229.61
170.254
8.316
7.932
Net Income from Continuing Operation Net Minority Interest
-53,747
-53,479
-28,060
-15,528
-15,190
Total Unusual Items Excluding Goodwill
-2,616
-890.252
1,328
961.316
662.14
Total Unusual Items
-2,616
-890.252
1,328
961.316
662.14
Normalized EBITDA
-48,274
-51,691
-30,702
-16,481
-16,507
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0